Statins provide net benefits at higher 10-year risks for cardiovascular disease (CVD) than are reflected in most current guidelines, and the level at which these benefits occur varies by age, sex, and statin type, according to a recent modeling study. Researchers sought to identify the expected risk above which statins provide net benefit. Interventions included low- or moderate-dose statin vs no statin in persons aged 40-75 years with no history of CVD. Outcome measures included 10-year risk for CVD at which statins provide at least a 60% probably of net benefit, with baseline risk, frequencies of and preferences for statin benefits and harms, and competing risk for non-CVD death. Among the findings:
- Younger men had a net benefit at a lower 10-year risk for CVD than older men.
- The risk required for net benefit was higher in women.
- Atorvastatin and rosuvastatin provided net benefit at lower 10-year risks than simvastatin and pravastatin.
Yebyo HG, Aschmann HE, Puhan MA. Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: A modeling study. [Published online ahead of print December 4, 2018]. Ann Intern Med. doi: 10.7326/M18-1279.
Must Reads in Cardiology
Consumption of SSBs & Risk of Mortality, Circulation; ePub 2019 Mar 18; Malik, et al
Dietary Cholesterol or Egg Consumption & CVD, JAMA; 2019 Mar 19; Zhong, Van Horn, et al
Physical Activity & Incidence of CHD & CVD in Women, JAMA Netw Open; ePub 2019 Mar 15; LaCroix, et al